摘要：SummaryTumors comprised a tightly surrounded tumor microenvironment, made up of non-cellular extracellular matrix (ECM) and stromal cells. Although treatment response is often attributed to tumor heterogeneity, progression and malignancy are profoundly influenced by tumor cell interactions with the surrounding ECM. Here, we used a tumor organoid model, consisting of hepatic stellate cells (HSCs) embedded in collagen type 1 (Col1) and colorectal cancer cell (HCT-116) spheroids, to determine the relationship between the ECM architecture, cancer cell malignancy, and chemoresistance. Exogenous transforming growth factor beta (TGF-β) used to activate the HSCs increased the remodeling and bundling of Col1 in the ECM around the cancer spheroid. A dense ECM architecture inhibited tumor cell growth, reversed their mesenchymal phenotype, preserved stem cell population, and reduced chemotherapy response. Overall, our results demonstrate that controlled biofabrication and manipulation of the ECM in tumor organoids results enables studying tumor cell-ECM interactions and better understand tumor cell response to chemotherapies.Graphical AbstractDisplay OmittedHighlights•A 3D tumor organoid model with stromal cells and colorectal cancer cell spheroids•ECM architecture influences cancer cell phenotype, malignancy, and chemoresistance•Denser ECM reverses tumor cell mesenchymal phenotype and preserves stem cell population•Looser ECM architecture supports mesenchymal phenotype and increased chemosensitivityBiological Sciences; Cancer; Bioengineering
